Dendritic spine density, morphology, and fibrillar actin content surrounding amyloid-β plaques in a mouse model of amyloid-β deposition

Journal of Neuropathology and Experimental Neurology

Volumn 72, Issue 8, 2013, Pages 791-800

  Kirkwood, Caitlin M ^a   Ciuchta, Jennifer ^a   Ikonomovic, Milos D ^a,b   Fish, Kenneth N ^a   Abrahamson, Eric E ^b   Murray, Patrick S ^a   Klunk, William E ^a,b   Sweet, Robert A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer disease; Amyloid A; Dendritic spine; Genetic mouse models; Phalloidin; X 34

Indexed keywords

AMYLOID BETA PROTEIN; F ACTIN; PHALLOIDIN;

AMYLOID PLAQUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL DENSITY; CELL STRUCTURE; CONTROLLED STUDY; DENDRITIC SPINE; FEMALE; FLUORESCENCE; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LONG TERM DEPRESSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACTINS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; DENDRITIC SPINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MICE; MICE, TRANSGENIC; NEURONS; PLAQUE, AMYLOID; PRESENILIN-1;

EID: 84880918212     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31829ecc89     Document Type: Article

References (49)

1. Selkoe DJ. Alzheimer disease: Mechanistic understanding predicts novel therapies. Ann Intern Med 2004;140:627-38
2. Ballatore C, Lee VM, Trojanowski JQ. tau-Mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 2007;8: 663-72 (Pubitemid 47283144)
3. Ingelsson M, Fukumoto H, Newell KL, et al. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 2004;62:925-31 (Pubitemid 38435780)
4. DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Ann Neurol 1990; 27:457-64 (Pubitemid 20149963)
5. Scheff SW, Price DA, Schmitt FA, et al. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 2007; 68:1501-8 (Pubitemid 46685921)
6. Walsh DM, Selkoe DJ. A beta oligomersVa decade of discovery. J Neurochem 2007;101:1172-84
7. Walsh DM, Klyubin I, Shankar GM, et al. The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention 1. Biochem Soc Trans 2005;33:1087-90 (Pubitemid 41659119)
8. Hsieh H, BoehmJ, Sato C, et al. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 2006;52:831-43 (Pubitemid 44828454)
9. Shankar GM, Bloodgood BL, Townsend M, et al. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 2007;27:2866-75 (Pubitemid 46438992)
10. Spires TL, Meyer-Luehmann M, Stern EA, et al. Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J Neurosci 2005;25: 7278-87 (Pubitemid 41113944)
11. Tsai J, Grutzendler J, Duff K, et al. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat Neurosci 2004;7:1181-83 (Pubitemid 39426234)
12. Koffie RM, Meyer-Luehmann M, Hashimoto T, et al. Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci U S A 2009; 106:4012-17
13. Grutzendler J, Helmin K, Tsai J, et al. Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease. Ann N Y Acad Sci 2007;1097:30-39 (Pubitemid 47084880)
14. Matsuzaki M, Honkura N, Ellis-Davies GC, et al. Structural basis of long-term potentiation in single dendritic spines. Nature 2004;429:761-66 (Pubitemid 38833127)
15. Okamoto K, Nagai T, Miyawaki A, et al. Rapid and persistent modulation of actin dynamics regulates postsynaptic reorganization underlying bidirectional plasticity. Nat Neurosci 2004;7:1104-12 (Pubitemid 41184451)
16. Zhou Q, Homma KJ, Poo MM. Shrinkage of dendritic spines associated with long-term depression of hippocampal synapses. Neuron 2004;44: 749-57 (Pubitemid 39575629)
17. Nagerl UV, Eberhorn N, Cambridge SB, et al. Bidirectional activitydependent morphological plasticity in hippocampal neurons. Neuron 2004; 44:759-67 (Pubitemid 39575630)
18. Shankar GM, Li S, Mehta TH, et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 2008;14:837-42
19. Wang HW, Pasternak JF, Kuo H, et al. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res 2002;924:133-40 (Pubitemid 34102301)
20. Hsiao K, Chapman P, Nilsen S, et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996;274: 99-102 (Pubitemid 26332733)
21. Duff K, Eckman C, Zehr C, et al. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin. Nature 1996;383:710-13 (Pubitemid 26360645)
22. Holcomb L, Gordon MN, McGowan E, et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 1998;4:97-100 (Pubitemid 28133087)
23. Watson RE Jr, Wiegand SJ, Clough RW, et al. Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptides 1986;7:155-59 (Pubitemid 16082879)
24. Paxinos G, Franklin K. The Mouse Brain in Stereotaxic Coordinates: Compact Second Edition. New York: Elsevier. 2004
25. Ikonomovic MD, Abrahamson EE, Isanski BA, et al. X-34 labeling of abnormal protein aggregates during the progression of Alzheimer's disease. Methods Enzymol 2006;9:123-44 (Pubitemid 44548578)
26. Zempel H, Thies E, Mandelkow E, et al. Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous tau into dendrites, tau phosphorylation, and destruction of microtubules and spines. J Neurosci 2010; 30:11938-50
27. Kayed R, Canto I, Breydo L, et al. Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Abeta oligomers. Mol Neurodegener 2010;5:57
28. Kamal A, Almenar-Queralt A, LeBlanc JF, et al. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 2001;414:643-48 (Pubitemid 33151260)
29. Capani F, Deerinck TJ, Ellisman MH, et al. Phalloidin-eosin followed by photo-oxidation: A novel method for localizing F-actin at the light and electron microscopic levels. J Histochem Cytochem 2001;49:1351-61 (Pubitemid 33000794)
30. Fish KN, Sweet RA, Deo AJ, et al. An automated segmentation methodology for quantifying immunoreactive puncta number and fluorescence intensity in tissue sections. Brain Res 2008;1240:62-72
31. Sugiyama Y, Kawabata I, Sobue K, et al. Determination of absolute protein numbers in single synapses by a GFP-based calibration technique. Nat Methods 2005;2:677-84 (Pubitemid 41223094)
32. Luther E, Kamentsky L, Henriksen M, et al. Next-generation laser scanning cytometry. Methods Cell Biol 2004;75:185-218
33. Wilson LM, Mok YF, Binger KJ, et al. A structural core within apolipoprotein C-II amyloid fibrils identified using hydrogen exchange and proteolysis. J Mol Biol 2007;366:1639-51 (Pubitemid 46215613)
34. Korobova F, Svitkina T. Molecular architecture of synaptic actin cytoskeleton in hippocampal neurons reveals a mechanism of dendritic spine morphogenesis. Mol Biol Cell 2010;21:165-76
35. Hayashi K, Ishikawa R, Ye LH, et al. Modulatory role of drebrin on the cytoskeleton within dendritic spines in the rat cerebral cortex. J Neurosci 1996;16:7161-70 (Pubitemid 26382893)
36. Bamburg JR, Bloom GS. Cytoskeletal pathologies of Alzheimer disease. Cell Motil Cytoskeleton 2009;66:635-49
37. Davis RC, Marsden IT, Maloney MT, et al. Amyloid beta dimers/trimers potently induce cofilin-actin rods that are inhibited by maintaining cofilinphosphorylation. Mol Neurodegen 2011;6,10
38. Lorenzo A, Yankner BA. beta-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc Natl Acad Sci U S A 1994; 91:12243-47 (Pubitemid 24368641)
39. Iversen LL, Mortishire-Smith RJ, et al. The toxicity in vitro of beta-amyloid protein. Biochem J 1995;311:1-16
40. Walsh DM, Klyubin I, Fadeeva JV, et al. Amyloid-beta oligomers: Their production, toxicity and therapeutic inhibition. Biochem Soc Trans 2002; 30:552-57 (Pubitemid 35001597)
41. Lue LF, Kuo YM, Roher AE, et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 1999;155:853-62 (Pubitemid 29426831)
42. Valle-Delgado JJ, Alfonso-Prieto M, de Groot NS, et al. Modulation of Abeta42 fibrillogenesis by glycosaminoglycan structure. FASEB J 2010; 24:4250-61
43. Ittner LM, Gotz J. Amyloid-beta and tauVA toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci 2011;12:65-72
44. Gu J, Zheng JQ. Microtubules in dendritic spine development and plasticity. Open Neurosci J 2009;3:128-33
45. Urbanc B, Cruz L, Le R, et al. Neurotoxic effects of thioflavin SYpositive amyloid deposits in transgenic mice and Alzheimer's disease. Proc Natl Acad Sci U S A 2002;99:13990-95 (Pubitemid 35257612)
46. Jack CR Jr, Vemuri P, Wiste HJ, et al. Evidence for ordering of Alzheimer disease biomarkers. Arch Neurol 2011;68:1526-35
47. Landis DM, Reese TS. Cytoplasmic organization in cerebellar dendritic spines. J Cell Biol 1983;97:1169-78 (Pubitemid 13017113)
48. Sheng M, Hoogenraad CC. The postsynaptic architecture of excitatory synapses: A more quantitative view. Annu Rev Biochem 2007;76:823-47
49. Sweet RA, Fish KN, Lewis DA. Mapping synaptic pathology within cerebral cortical circuits in subjects with schizophrenia. Front Hum Neurosci 2010;4,44-75